Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

A national lens on follicular lymphoma: Academic care linked to improved survival in 158,000 patients

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDaniel RosasLBLeyla BojaniniSKSupreet Kaur

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows significant survival advantages in follicular lymphoma patients treated at academic centers, indicating better outcomes with specific treatment approaches.

Key Points

  • Overall survival for patients treated at Academic Cancer Programs was significantly longer at 13.95 years compared to 12.68 years for Community Cancer Programs.
  • The study analyzed 158,994 patients diagnosed with follicular lymphoma, comparing treatment outcomes across two types of cancer facilities.
  • Analysis utilized Kaplan-Meier and Cox models to evaluate overall survival, adjusting for key demographics and clinical factors.
  • The findings suggest that multidisciplinary expertise at Academic Cancer Programs has critical implications for improving patient outcomes.

Cite This Study

Rosas et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d7d6https://doi.org/10.1182/blood-2025-2628
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patients with burkitt's lymphoma have a better survival probability if treated in an academic cancer program2025
  2. 2Academic cancer programs deliver improved long-term survival in nodular lymphocyte predominant Hodgkin lymphoma: Insights from 7,000+ United States patients2025
  3. 3The academic center effect: Better outcomes for patients with DLBCL2025
  4. 4Outcomes of primary cutaneous anaplastic large cell lymphoma across u.S. cancer care settings: A national cancer database analysis.2025
  5. 5Unequal outcomes: The role of institutional setting in the management of primary CNS lymphoma2025 · 1 citations